Did you know that 5% of men under 30 have prostate cancer and that number is as high as 70% over 70? Did you know that even though it can kill you, your doctor might recommend not treating it?
cells from prostate cancer patients with short telomeres and hypervariable lengths were 14X more likely to die of their disease
It is said that 70% of men over 70 have prostate cancer. Does telomerase activation impact the incidence, severity, or recurrence?
I am passing along this request for funding from Jill Runion, my friend and the clinician who has cared for Porter since 2007. In this podcast, I discuss his amazing journey from spinal cord injury which can provide hope for many others.
After two years of TA-65 use, his median length is now 12,500 (from an estimated 9,400) with a very nice drop in critically-short telomeres to 4.5% (from a baseline of up to 20%). So if you believe what most research is showing regarding the connection between shorter telomeres and longevity, Mark has gained over 30 years of longevity in a time where he should have lost three years.
In keeping with the findings that healthy behaviors are good for you because they impact your telomeres, we now add sleep to the list of such behaviors that includes exercise, Mediterranean Diet, and meditation:
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
